Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Everolimus in de novo kidney transplant patients (ZEUS study)
NCT00514514Phase 3Completed
- Sponsor
- Novartis
- Start
- Jul 2007
- Primary completion
- Jun 2015
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 3, randomised, open-label trial of everolimus in kidney transplantation, sponsored by Novartis. Started Jul 2007; status: completed.
02
Drugs
everolimus
03
Conditions
kidney transplantation
Beyond the preview
Go deeper on NCT00514514.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00514514.